Pro-Photoreceptor Activity of Chick neurogenin1

Abstract

Purpose.: Better understanding of photoreceptor fate specification may lead to efficient production of photoreceptors for cell replacement studies. The authors investigated the role of proneural bHLH gene neurogenin1 (ngn1) in photoreceptor genesis using the chick retina.

Methods.: In situ hybridization was used to delineate the spatial and temporal pattern of ngn1 expression. RCAS retrovirus was used to drive overexpression of ngn1 in retinal cells, and siRNA was used to reduce ngn1 expression in loss-of-function experiments.

Results.: Chick ngn1 was transiently expressed during early phases of retinal neurogenesis, from embryonic day (E)3 to E6, with cells expressing ngn1 confined to the apical side of the retinal neuroepithelium. The time window and the anatomic location of ngn1 expression coincided with photoreceptor genesis and differed from those of other transiently expressed proneural bHLH genes, such as ash1, ath3, ath5, and ngn2. Most ngn1-expressing cells lacked BrdU incorporation and lacked phosphorylated histone H3. In low-density cell culture, ngn1 overexpression increased neuroD expression and expanded the photoreceptor population but reduced the ganglion population. Treatment of dissociated retinal cells with siRNA against ngn1 mRNA specifically reduced the photoreceptor population. Overexpression of ngn1 in the retina reduced the expression of ash1, ath5, chx10, and ngn2.

Conclusions.: The data suggest that ngn1 participates in a complex transcriptional network and may play a role in guiding a progenitor cell to the photoreceptor pathway.

Photoreceptors are specialized sensory neurons in the retina. Because they are terminally differentiated and do not reenter the cell cycle for regeneration, photoreceptors lost for various reasons cannot be replenished, leading to irreversible blindness. ^1,2 One of the potential therapies is cell replacement with developing photoreceptors. ³ This promising approach faces a major roadblock—the need for a supply of photoreceptors. ⁴ As a result, attention has been directed to inducing photoreceptor genesis through programming or reprogramming the differentiation of cells that can be propagated in large amounts. Key to this approach is knowledge of the decision-making factor(s) that can guide a progenitor cell to the path of differentiating into a photoreceptor. 

The photoreceptors and their “siblings” (i.e., the other five major types of retinal cells) arise from a pool of multipotent progenitors during vertebrate retinal development. ⁵ What dictates photoreceptor fate over other options during retinal neurogenesis has been a central question in the developmental biology of the retina. Photoreceptor development and maturation require a number of regulatory genes, such as homeodomain genes crx ^6–8 and raxL, ⁹ the neural retina leucine-zipper gene NRL, ^10,11 thyroid hormone receptor TRβ2, ¹² and basic helix loop-helix (bHLH) gene neuroD. ^13–15 Whether there is a single key factor dictating photoreceptor fate remains elusive. 

Proneural bHLH genes have been shown to play important roles in specifying neural fates/diversities in both the central nervous system and the peripheral nervous system. The developing vertebrate retina expresses several such genes, such as achaete-scute homologue 1 (ash1), atonal homologue 3 (ath3), ath5, neuroD, neurogenin1 (ngn1), ngn2, ngn3, NSCL1, and NSCL2. Proneural bHLH genes known to be expressed in retinal progenitor cells include ash1, ath3, ngn1, ngn2, and ngn3. ^16–21 Analysis of retinal explants derived from ash1-null mice indicated that ash1 participates in the production of late-born neurons, including rod photoreceptors and bipolar cells. ²² In the chick retina, ash1 was proposed to promote amacrine cells, ²³ and this was later confirmed experimentally. ²⁴ Studies have indicated ath3 in the production of bipolar and amacrine cells. ^25–27 Ngn2 is expressed in the proliferating zone, ^25,28 including cells still in the cell cycle. ^29,30 In the mouse retina, regions lacking ngn2 expression contain no photoreceptor cells, indicating that ngn2 has a role in photoreceptor genesis. ²⁸ Analyses of retinas from double and triple knockouts indicate that ngn2 may also play an important role in horizontal cell genesis. ³¹ A fate-mapping study showed that cells expressing ngn2 develop into all major cell types in the mouse retina. ³⁰ Chick ngn3 is transiently expressed during early retinal neurogenesis, and its overexpression increases the population of ganglion cells such that they expand into the territory normally occupied by amacrine cells. Overexpression of ngn3 induces ngn1 expression while suppressing the expression of ngn2, ash1, and ath3. ²¹ The role of ngn1 in retinal cell fate specification is not well established, even though ngn1 is known to play a determinative role in the brain in generating neural diversity. ^32,33 Perron et al. ¹⁶ reported a specific, albeit moderate, increase in the photoreceptor population on overexpression of a related gene, ngnr1, in Xenopus retina. Thummel et al. ²⁰ found that zebrafish ngn1 is expressed in developing retina and during photoreceptor regeneration after light-induced photoreceptor degeneration. These studies suggest that ngn1 may be involved in photoreceptor generation. 

We have investigated the expression of ngn1 in the developing chick retina and the role of ngn1 in retinal cell generation. We report that the expression of chick ngn1 was transient and restricted to early neurogenesis, with a spatial and temporal window of expression coinciding with the generation of photoreceptor precursor cells. In retinal cell culture, ngn1 overexpression increased the photoreceptor population at the expense of ganglion cells, whereas siRNA against ngn1 reduced the photoreceptor population. Overexpression of ngn1 in the developing retina reduced the expression of other regulatory genes. These results suggest that ngn1 participates in regulatory networks governing retinal neurogenesis and has a role in leading progenitor cells to take the photoreceptor pathway. 

Materials and Methods

Chick Embryos

Fertilized, pathogen-free White Leghorn chicken eggs were purchased from Spafas (Norwich, CT) and were incubated (Petersime Incubator, Gettysburg, OH). All use of animals adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the procedures and policies set by the Institutional Animal Use and Care Committee at the University of Alabama at Birmingham. 

Generation of RCAS-ngn1 Retrovirus

Based on published information, ³⁴ we amplified the coding region of chick ngn1 with RT-PCR. After cloning and sequence verification, the DNA was subcloned into shuttle vector Cla12Nco and then inserted into proviral vector RCAS. ³⁵ Virus particles were produced by transfecting chick embryonic fibroblast cells with the recombinant proviral DNA. Concentrated viral stocks (∼1 × 10⁸ pfu/mL) were prepared as described. ³⁶  

Microinjection of Retrovirus into Chick Embryos

Concentrated RCAS-ngn1 virus, or control RCAS-GFP virus, ³⁶ was microinjected into the neural tube and the subretinal space (between the two layers of the optic cup) of embryonic day (E)2.5 chicks (stages 15–17), as previously described. ³⁶ Infected eyes were enucleated at various developmental stages and fixed with ice-cold 4% paraformaldehyde, cryoprotected with OCT/sucrose (2:1), frozen with liquid nitrogen, and kept at −80°C. Infection by RCAS viruses (RCAS-ngn1 and RCAS-GFP) was visualized by immunostaining with an antibody against viral protein p27. 

Low-Density Retinal Cell Culture

Retinas (n = 3–16) were dissected from E4.5 to E8.5 chick embryos infected with RCAS-ngn1 or RCAS-GFP as control. Retinal cells were dissociated with trypsin-EDTA and seeded into the wells of 24-well plates treated with polyornithine at a density that covered less than one-fifth of the surface area. After 4 days in culture with medium (Medium 199; Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal calf serum, cells were fixed with ice-cold 4% paraformaldehyde, then subjected to immunostaining or in situ hybridization. For experiments with E4.5 and E8.5 retinas, double-labeling for viral (p27) and retinal markers was carried out. The number of positive cells and the number of total cells were scored from nine view areas from each culture well, each with 40 to 300 cells, under a 20× objective. The percentage of positive cells was calculated for one well, and the mean ± SD from three wells were calculated with a computer program (Origin 7.0; OriginLab Corp., Northampton, MA). 

Low-Density Retinal Cell Culture with siRNA

Retinal cells from E4.5 chick embryos were seeded at low density, as described. Polyornithine-treated glass coverslips were coated with siRNA immediately before cell seeding. Two predesigned siRNAs (Silencer Select; Ambion, Applied Biosystems, Foster City, CA) against ngn1, uucgauuuuggugaguuugGT and uaagggugugcagcaaagcCT, were selected and synthesized. One (Silencer Select Negative Control #1 siRNA; Ambion) was used as a control. SiRNA and the transfection agent (siPORT NeoFX; Ambion) were mixed according to the manufacturer's instructions and were added to the cell culture at a final concentration of 300 nM. The culture was maintained for 2 or 4 days before fixation for immunocytochemistry, in situ hybridization, or TUNEL analysis. Scoring cell numbers and statistical analysis were as described. 

In Situ Hybridization

Digoxigenin (Dig)-labeled antisense RNA probe against ngn1 was prepared from linearized plasmids harboring the coding sequence (Genius kit; Roche Molecular Biochemicals, Indianapolis, IN) according to the manufacturer's instructions. Dig-labeled antisense RNA probes against chick ash1, ²¹ ath3, ³⁷ ath5, ³⁸ chx10, ³⁷ neuroD, ³⁶ ngn2, ²⁹ and ngn3 ²¹ were prepared as described. Retinal cryosections 10-μm thick were used for in situ hybridization according to procedures described previously. ³⁷  

Immunocytochemistry

The following monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank (University of Iowa): anti-bromodeoxyuridine (BrdU; clone G3G4, 1:100; developed by Stephen J. Kaufman), anti-islet-1 (clone 39.4D5, 1:100; developed by Thomas Jessell), anti-AP2α (3B5, 1:50; developed by Trevor Williams), and anti-visinin (clone 7G4, 1:500; developed by Constance Cepko). Antibodies obtained from a commercial source included monoclonal antibody against Brn3a (1:200; Chemicon, Temecula, CA), polyclonal antibody against red opsin (1:200; Chemicon), polyclonal antibody against calretinin (1:500; Chemicon), anti-phosphorylated histone H3 (1:200; Upstate Biotechnology, Lake Placid, NY), and polyclonal antibody against an RCAS viral protein, p27 (1:500; Spafas). Monoclonal antibody RA4 (1:1000 dilution) was a gift from Steven McLoon (University of Minnesota). A monoclonal antibody against chick NeuroD was produced in our laboratory. Standard immunocytochemistry was performed with secondary antibodies conjugated with peroxidase, alkaline phosphatase (Vector Laboratories, Burlingame, CA), or fluorophore (Molecular Probes, Eugene, OR). 

TUNEL Assay

TUNEL assay was used to detect the presence of apoptotic cells in E4.5 retinal cell culture (In Situ Cell Death Detection Kit; Roche Molecular Biochemicals) according to the manufacturer's instruction. 

Pulse-Labeling Chick Embryos with BrdU

BrdU (50 μg in 50 μL HBSS) was dropped through an opening in the shell onto the vitelline membrane of E5 and E7.5 chick embryos. The embryos were incubated for 3 hours before the eyes were harvested and fixed with 4% paraformaldehyde. For double-labeling, cryosections were first subjected to in situ hybridization with Dig-labeled anti-ngn1 RNA probes and then to BrdU detection using a specific antibody, as previously described. ³⁷  

Results

Transient ngn1 Expression in Early Retinal Development

To gain a perspective on how ngn1 might function in the retina, its expression was examined and compared with the expression of some better studied proneural bHLH genes. The earliest retinal expression of ngn1 detected with Dig-labeled antisense RNA probes was E2.5, when some positive cells were observed at the central region (Fig. 1A). At this time, ath5 expression was visible in only a few cells (Fig. 1B), whereas no ngn2 expression was evident (Fig. 1C). Expression of ngn1 (Fig. 1D), ath5 (Fig. 1E), ngn2 (Fig. 1F), and ash1 (Fig. 1G) was visible in the E3.5 retina. Starting from E4.5, differences emerged in the spatial expression patterns of the genes. Cells expressing ngn1 localized to the outermost zone in the pseudostratified retinal neuroepithelium at E4.5 (Fig. 1H) and E5.5 (Fig. 1J), an anatomic location of newly born photoreceptor precursors. This spatial pattern is similar to neuroD expression (Fig. 1L). Chick neuroD is expressed in young photoreceptor cells or their precursors. ^14,36 However, neuroD expression is not evident in retinas younger than E5. ³⁶ Thus, ngn1 expression preceded that of neuroD. Cells expressing ath5 localized mostly to the vitreal side (Fig. 1I), and cells expressing ngn2 were distributed across the neuroepithelium (Fig. 1K). Expression of ngn1 began to decrease in the E6 central retina (data not shown), and by E7.5 the expression of ngn1 was no longer detectable in the central region (Fig. 1M). This temporal pattern coincided with photoreceptor genesis, which in the chick retina takes place primarily between E5 and E7. ³⁹ The E7.5 retina continued the expression of ath5 (Fig. 1N), ngn2 (Fig. 1O), ash1 (Fig. 1P), and neuroD (Fig. 1Q). Each distinctive spatial pattern was maintained except in ath5, which had an additional zone of expression in the outer portion of the retinal neuroepithelium. Overall, though partially overlapping with ngn3 expression, ²¹ ngn1 expression differed spatially and temporally from that of ath5, ngn2, neuroD, and ash1. 

Figure 1.

 

The expression pattern of ngn1 in the developing chick retina in comparison with other proneural bHLH genes. (A–C) In situ hybridization of serial sections to detect the expression of ngn1 (A), ath5 (B), and ngn2 (C) in the E2.5 eye. (D–G) In situ hybridization of serial sections to detect the expression of ngn1 (D), ath5 (E), ngn2 (F), and ash1 (G) in the E3.5 eye. (H, I) Spatial expression patterns of ngn1 (H) and ath5 (I) in E4.5 retinas. (J–L) Spatial expression patterns of ngn1 (J), ngn2 (K), and neuroD (L) in E5.5 retinas. (M–Q) Spatial expression patterns of ngn1 (M), ath5 (N), ngn2 (O), ash1 (P), and neuroD (Q) in E7.5 retinas. In situ hybridization signals were developed with nitroblue tetrazolium, except in ngn1 (J), in which rhodamine-tyramide was used. (A–G, arrows) Retinal cells expressing the respective gene. Asterisk: RPE layer. Scale bars, 100 μm.

In addition to coinciding with the prospective location of photoreceptor cells, the localization of ngn1-expressing cells to the outermost region of the retinal neuroepithelium also coincided with the location of M-phase cells. To determine whether ngn1 expression defined M-phase cells, double-labeling for phosphorylated histone H3 (phospoH3) and for ngn1 mRNA was carried out. Double-labeled cells were detected (Figs. 2A–C) but accounted for approximately 10% of the phospoH3⁺ cells and approximately 5% of the ngn1 mRNA⁺ cells. A typical view area under a 40 × objective contained three double-labeled cells from 26 phospoH3⁺ cells and 60 ngn1 mRNA⁺ cells. To determine whether ngn1-expressing cells were cycling or postmitotic, double-labeling for ngn1 expression and BrdU incorporation was carried out after the embryo was pulsed with BrdU. Only a small number of double-labeled cells were detected in the retina (Fig. 2D) and the brain (Fig. 2E). In a typical view area with a 40 × objective, four were double-labeled, representing 7% of the 61 ngn1 mRNA⁺ cells and 3% of the 156 BrdU⁺ cells. Thus, most ngn1-expressing cells lacked phospoH3 or BrdU incorporation. 

Figure 2.

 

Double labeling for ngn1 expression and cell proliferation. (A–C) Double-labeling for ngn1 mRNA (A, blue) and phosphorylated histone H3 (B, green) in the E6 retina. (C) Simultaneous view of both. (D, E) Double-labeling for ngn1 mRNA (blue) and BrdU incorporation (red) in the E5 retina (D) and the brain (E). (D, inset) Clearer image of double-labeled cells. Arrows: cells positive for ngn1 mRNA but negative for BrdU or phospoH3. Short red arrows: double-labeled cells. Scale bar, 50 μm.

Effect of ngn1 Overexpression on Retinal Neurogenesis

The replication-competent avian leukosis virus RCAS ³⁵ was used to drive the overexpression of ngn1 in chick embryos. This virus infects an increasing number of cells over time in a population of proliferating cells because viruses released from infected cells can infect other cells. ^40,41 RCAS infection and transduction do not affect retinal development; we observed no abnormalities either at the gross level or at the microscopic level from hundreds of embryos infected with RCAS or RCAS-GFP. ^21,24,42,43 Analyses of cell populations in regions infected with RCAS-GFP against the adjacent uninfected regions revealed no differences in the numbers of AP2⁺ cells, Pax6⁺ cells, chx10⁺ cells, visinin⁺ cells, BrdU⁺ cells, or ngn2⁺ cells. ²⁴ RCAS-ngn1, or RCAS-GFP, was microinjected into the lumen of the neural tube and the subretinal space at E2.5 (∼64 hours of incubation) through approximately E3 (70 hours of incubation) ²⁴ because during this time the neural tube and the subretinal space remain connected. Expression of the transgene was expected to begin at approximately E3.5 and to persist thereafter until the retina was harvested for analysis, based on the fact that transgene expression becomes apparent 21 to 24 hours after infection. ^40,41 Previous studies showed that RCAS-driven overexpression of bHLH genes may alter retinal neurogenesis in a gene-specific manner. ^{21,24,44–46} Retinal sections from embryos infected with RCAS-ngn1 were examined histologically, followed by immunohistochemistry with antibodies that recognize specific cell types. Retinas from embryos (n > 50) microinjected with RCAS-ngn1 displayed no obvious alterations in histology or in retinal neurogenesis. For unequivocal evidence, we compared immunostaining of regions infected by RCAS-ngn1 with adjacent, uninfected regions on the same retinal section to minimize ambiguities arising from comparing retinas that could vary because of differences in developmental stages or angles at which the retinas were sectioned. Molecular analyses with specific antibodies showed no changes in the populations of photoreceptor (visinin⁺; Figs. 3A, 3B), amacrine (AP2α⁺; Figs. 3C, 3D), or ganglion cells (Brn3A⁺; Figs. 3E, 3F). 

Figure 3.

 

Double staining of E7.5 retinas partially infected by RCAS-ngn1 for alterations in retinal neurogenesis. (A, B) Double-labeling for RCAS viral protein p27 (A) and photoreceptor protein visinin (Vis; B). (C, D) Double-labeling for viral protein p27 (C) and amacrine protein AP2α (D). (E, F) Double-labeling for viral protein p27 (E) and ganglion protein Brn3A (F). (G, H) Double-labeling for viral protein p27 (G) and neuroD mRNA (H). (I, J) Double-labeling for viral protein p27 (I) and ath3 mRNA (J). (K, L) Double-labeling for viral protein p27 (K) and chx10 mRNA (L). (M, N) Double-labeling for viral protein p27 (M) and ath5 mRNA (N). Infected regions are underlined. Of note, in some of the double-fluorescent images (C–F), the anti-p27 signals were so strong that they were also visible under the filter used to view the anti-AP2α (D) or anti-Brn3A (F) signals, resulting in optical spillover. The genuine anti-AP2α (D) or anti-Brn3A (F) signals can be distinguished by their nucleus localization from the optical spillover of anti-P27 signals in the cytoplasm. Scale bar, 100 μm.

Effects on Regulatory Gene Expression by ngn1 Overexpression

To determine whether ngn1 overexpression might have altered gene expression without concomitant alterations in cell production, we examined the retinas infected with RCAS-ngn1 for the expression of a number of regulatory genes involved in different retinal cell populations. For the analysis, uninfected regions in the same retinal sections were used as internal controls to avoid ambiguities from comparing different retinal sections that potentially differed in developmental stage or angle of sectioning. In retinas infected with RCAS-ngn1, expression of neuroD (Figs. 3G, 3H) remained unchanged, despite the spatial similarity of their expression. Expression of ath3, which plays an important role in the development of progenitor cells and bipolar cells, ²⁷ also remained unaltered with ngn1 overexpression (Figs. 3I, 3J; see Fig. 5G). On the other hand, expression of chx10, a homeodomain gene with important roles in the development of progenitor cells and bipolar cells, ⁴⁷ was essentially abolished in the region infected with RCAS-ngn1, whereas in the adjacent uninfected region, a high level of chx10 expression was observed (Figs. 3K, 3L; see Fig. 5G). Ngn1 overexpression also reduced the expression of ath5 (Figs. 3M, 3N; see Fig. 5G) required for ganglion cell development (for review, see Mu and Klein ⁴⁸ ) and may also participate in the production of other retinal cells. ⁴⁹  

Ash1 plays a determinative role in generating neural diversity in other regions of the central nervous system. ^32,33 In the retina, ash1 expression is detected during both early and late phases of neurogenesis in a subpopulation of retinal progenitor cells, and it may participate in the generation of amacrine cells or rod photoreceptors and bipolar cells, which are the last born neurons in the retina. In E7.5 retina, ash1 expression was detected in cells within the proliferating zone, and the expression was unaffected by RCAS-GFP infection (Figs. 4A, 4B). In E7.5 retinas infected with RCAS-ngn1, expression of ash1 was abolished at the periphery (Figs. 4C–F), where neurogenesis was active, as reflected by the presence of a large number of ash1-expressing cells. Expression of ash1 was also decreased in the central retina (Figs. 4G, 4H), where neurogenesis was subsiding. The lack of ash1 expression was specific to the infected regions, whereas the adjacent uninfected region maintained ash1 expression. Suppression of ash1 expression was also observed in the brain (Figs. 4I, 4J). 

Figure 4.

 

Diminished ash1 expression in E7.5 retinas infected by RCAS-ngn1. (A, B) Control RCAS-GFP retina with double-labeling for RCAS viral protein p27 (A) and for ash1 mRNA (B). (C–H) RCAS-ngn1 partially infected retinas showing double-labeling for RCAS viral protein p27 (C, E, G) and for ash1 mRNA (D, F, H) in peripheral retina (C–F) and central retina (G, H). (C) and (D) are lower magnifications of (E) and (F). (I, J) Double-labeling for viral protein p27 (I) and ash1 expression (J) of E7.5 brain partially infected with RCAS-ngn1. Arrow: zone with diminished ash1 expression. In all panels, approximate infected regions are underlined. Scale bars, 100 μm.

Ngn2 is another regulatory gene involved in cell fate specification during neurogenesis in other regions of the central nervous system. ^32,33 In the retina, ngn2 expression spans early and late phases of cell neurogenesis, and it is thought to participate in the development of progenitor cells that eventually differentiate into all major types of retinal neurons. ^28–31 Infection with RCAS-GFP does not alter ngn2 expression. ²¹ In RCAS-ngn1-infected retinas, ngn2 was downregulated (Figs. 5A–D, 5G). The downregulation was observed where neurogenesis was active, as reflected by the presence of a large number of ngn2-expressing cells (Figs. 5A, 5B). The downregulation was also observed where neurogenesis was tapering off, as reflected by the presence of a relatively smaller number of ngn2-expressing cells (Figs. 5C, 5D). Notably, no suppression of ngn2 expression was apparent in the brain (Figs. 5E, 5F). This resistance to ngn1's suppression could be attributed to either ngn1 alone being insufficient to suppress ngn2 expression or other genes/factors promoting ngn2 in these particular cells, or both. 

Figure 5.

 

Downregulation of ngn2 expression in retinas infected with RCAS-ngn1. (A–D) Double-labeling for RCAS viral protein p27 (A, C) and for ngn2 mRNA (B, D) in E7.5 peripheral retina (A, B) and central retina (C, D). (E, F) Double-labeling for viral protein p27 (E) and ngn2 expression (F) in E7.5 brain partially infected with RCAS-ngn1. Approximate infected regions are underlined. Scale bar, 100 μm. (G) Mean ± SD of the ratio of the number of cells expressing each of the markers in infected regions over the number in uninfected regions.

Ngn3, the third member of the ngn subfamily, promotes early retinal neurogenesis in the chick. ²¹ Infection by RCAS-ngn3 results in ectopic expression of ngn1, suggesting an inductive relation of ngn3→ngn1. ²¹ To examine whether ngn1 could reciprocally induce ngn3, we examined E7.5 retinas infected with RCAS-ngn1 for ngn3 expression, considering that at this developmental stage the level of endogenous ngn3 expression is undetectable in normal retina. ²¹ No induction of ngn3 was found (data not shown). 

To examine the effect of ngn1 overexpression on cell proliferation, BrdU incorporation analysis was carried out. To minimize ambiguities arising from comparing retinas having different cell proliferation activities attributed to differences in developmental stages, the number of BrdU⁺ cells in regions infected by RCAS-ngn1 was compared with that in adjacent, uninfected regions of the same retinal section. Infection with RCAS-GFP did not change the number of BrdU⁺ cells (Figs. 6A, 6B, 6E). However, in regions infected with RACS-ngn1, fewer BrdU⁺ cells were present compared with the internal control (adjacent, uninfected region; Figs. 6C, 6D). Scoring the number of BrdU⁺ cells in regions of similar sizes showed a 40% reduction in the infected region (Fig. 6E). 

Figure 6.

 

Analyses of cell proliferation with BrdU incorporation of retinas infected with RCAS-ngn1. (A, B) Double-labeling for RCAS viral protein p27 (A) and for BrdU incorporation (B) of a control E7.5 retina with partial infection by RCAS-GFP. (C, D) Double-labeling for the viral protein p27 (C) and for BrdU incorporation (D) of an E7.5 retina with partial infection by RCAS-ngn1. Infected regions are underlined. Scale bar, 100 μm; applies to all panels. (E) A plot of the ratios of BrdU⁺ cells in infected regions over adjacent, uninfected regions. **P < 0.01; statistically significant difference from the control.

Effects on Retinal Populations from Manipulating ngn1 Expression In Vitro

One reason for the lack of changes in retinal cell populations from ngn1 overexpression could be cell contact-mediated feedback mechanisms circumventing the effect of the experimental manipulation on cell production. Ngn1 has been shown to induce and then be a target of Notch/delta-mediated lateral inhibition, ^50–52 which plays an important role in regulating retinogenesis. ^53–56 To minimize cell contact-mediated feedback modulation, low-density retinal cell culture ^38,53,57,58 was used to examine whether ngn1 could steer retinal progenitors to a particular path. Retinal cells were isolated at E4.5, when expression of ngn1 was high (Fig. 1H), and were cultured at low density for 4 days in vitro (4 DIV). We found that ngn1 induced an 84% increase in photoreceptor population (visinin⁺/p27⁺), from 32% of the total P27⁺ (infected) cells in the control (infected with RCAS-GFP) to 59% in the experimental retina (Fig. 7A; P < 0.01). This strong photoreceptor-promoting effect was still observed at E8.5 (Fig. 7B), when the retina normally no longer expressed ngn1. When the number of total cells, instead of infected cells, was used in the analysis, a milder effect was observed (Figs. 7C, 7D), likely caused by a dilution effect by uninfected cells. Consistent with the expansion of the photoreceptor population, the number of cells expressing neuroD was also increased (Figs. 7C, 7D). No significant change in AP2α⁺ or calretinin⁺ amacrine cells was observed (Figs. 7A, 7C). The number of cells expressing chx10 was reduced (Fig. 7C). The ganglion cell population (Islet-1⁺, RA4⁺, or Brn3A⁺) was also reduced. With retinal cells of E4.5, when a major portion of the cells born will take on a ganglion fate, the ganglion population was decreased by 42%, from 48% of the infected cells in the control to 28% in the experimental retinas (P < 0.01; Fig. 7A). A milder, yet significant (P < 0.01), reduction in ganglion population was observed with E4.8 cells (Fig. 7C). With E5.5 retinal cells, no significant reduction in the ganglion population was observed (Fig. 7D). 

Figure 7.

 

Quantitative analysis of alterations in retinal neurogenesis from ngn1 overexpression in dissociated retinal cells. (A) The percentage of double-labeled cells [p27⁺/visinin⁺ (Vis), p27⁺/AP2a⁺, or p27⁺/Islet⁺] over the total of p27⁺ cells in E4.5 retinal cell cultures. (B) The percentage of double-labeled cells (p27⁺/Vis⁺) over the total of p27⁺ cells in an E8.5 retinal cell culture. (C) The percentage of cells positive for visinin, NeuroD, Chx10, calretinin (Calr), or RA4 in E4.8 retinal cell cultures. (D) The percentage of cells positive for visinin, NeuroD, or Brn3A in E5.5 retinal cell cultures. Shown are the means ± SDs of the calculated percentage of cells identified with each marker. *P < 0.05 and **P < 0.01; statistically significant differences from control.

Low-density retinal cell culture was also used in siRNA knockdown experiments. Dissociated cells from E4.5 retinas were cultured in the presence, or absence, of siRNA against ngn1. In initial experiments, two siRNAs against ngn1 were used separately. We found that either of the two reduced the number of visinin⁺ cells significantly (P < 0.01), albeit mildly (Fig. 8A), whereas neither siRNA affected the number of Islet-1⁺ cells or Pax6⁺ cells (ganglion and amacrine). In subsequent experiments, the siRNAs were used in combination. To verify that the siRNA reduced ngn1 mRNA, we used in situ hybridization to identify cells with detectable levels of ngn1 mRNA in E4.5 retinal cell cultures 48 hours after siRNA treatment. In cultures receiving a control siRNA, approximately 10% of the cells were ngn1 mRNA⁺. The number was reduced by 25-fold, to 0.4% of total cells in cultures receiving siRNA against ngn1 (P < 0.01; Fig. 8B). At the same time, the number of NeuroD⁺ cells was reduced by more than 50%, from 52.9% ± 7.6% of the total cells in the culture treated with control siRNA to 22.6% ± 3.4% in the experimental culture (P < 0.01; Fig. 8B). The number of visinin⁺ cells was significantly (P < 0.05), yet mildly, reduced. There were no significant changes in the numbers of cells that were positive for RA4 (ganglion) or Pax6, BrdU incorporation, or expression of ngn2 or ash1 (Fig. 8B). There was a small, yet statistically significant (P < 0.05), reduction in the number of TUNEL⁺ cells, from 0.9% of the total cells in the control culture to 0.8% in the experimental culture. The results suggest that the reductions in the number of NeuroD⁺ cells and the number of visinin⁺ cells from treatment with siRNA against ngn1 were unlikely due to reduced cell proliferation or increased cell death. 

Figure 8.

 

Effect of siRNA against ngn1 on ngn1 mRNA and on retinal cell populations. (A) A plot of the means ± SDs of the percentage of cells positive for visinin (Vis), Islet, or Pax6 among dissociated E4.5 retinal cells cultured for 4 days under the treatments with transfection agent (NeoFx) alone or with a siRNA (#1 or #2) against ngn1. (B) A plot of the means ± SDs of the percentage of cells positive for each marker as specified among dissociated E4.5 retinal cells cultured for 2 (for data on ngn1, NeuroD, and TUNEL) or 4 days (for data on the other markers) under the treatments with control siRNA or siRNA against ngn1. *P < 0.05 and **P < 0.01; statistically significant differences from control.

Discussion

In the chick retina, ngn1 was expressed during the early phases of retinal neurogenesis, and the expression became undetectable during the later phases, when neurogenesis was still active. Expression of ngn1 likely occurred in both proliferating and postmitotic cells because only some of the ngn1-expressing cells incorporated BrdU or expressed phospoH3. Thus, it is plausible that ngn1 is expressed as a cell is undergoing the transition from proliferation to differentiation. 

Spatially, cells expressing ngn1 were confined to the outermost portion of the retinal neuroepithelium, the prospective location of photoreceptor cells. Transient expression has been considered a signature of genes specifying neural types. ³³ Thus, the temporal and spatial patterns of ngn1 expression are consistent with a role in photoreceptor fate specification. In support of this, overexpression of ngn1 in low-density cell culture resulted in an expansion of the photoreceptor population and an increase in number of cells expressing neuroD, which participates in photoreceptor production likely through promoting differentiation and survival. ^13–15,36 Conversely, the photoreceptor population was reduced when retinal cells were cultured in the presence of siRNA against ngn1. Not totally unexpected, in vivo overexpression of ngn1 did not produce noticeable alterations in retinal cell populations. This could result from confounding factors in the retina, including bHLH factors cross-regulating one another through networks or cascades. ^21,31 Indeed, we have observed that overexpression of ngn1 diminished the expression of ash1, ath5, and ngn2, all of which participate in the genesis of different types of retinal cells, including photoreceptors. ^{22,28,30,38,49} Another potential reason for the lack of alteration in retinal cell populations from ngn1 overexpression is the presence of a cell contact-mediated feedback mechanism theorized to participate in the global regulation over retinogenesis that results in a balanced production of all cell types. This could explain why, with low-density cell culture, we detected ngn1's photoreceptor-promoting activity. Ngn1 promoting photoreceptor production is consistent with the limited information that is available in the literature. In Xenopus retina, the ngn1-related gene ngnr1 specifically increases the photoreceptor population. ¹⁶ In zebrafish retina, ngn1 is expressed both in development and during photoreceptor regeneration after light-induced photoreceptor degeneration. ²⁰ Little is known about the function of ngn1 in mouse retinal development. In the brain, ngn1 plays a determinative role in generating neural diversity. ^32,33  

During retinal neurogenesis, a number of proneural bHLH genes are expressed. Among them, ngn1 showed a spatial and temporal pattern of expression similar only to that of ngn3. Both were switched off early, when retinal neurogenesis in the chick was still active and the expression of other bHLH regulatory genes (ath5, ngn2, and ash1) remained high. Temporally, expression of ngn3 precedes the expression of ngn1. ²¹ Spatially, expression of ngn3, but not ngn1, was also detected on the vitreal side, the prospective location of ganglion cells. Overexpression of ngn3 results in an expansion of the ganglion population into the territory otherwise occupied by amacrine cells. ²¹ Overexpression of ngn1, however, reduced the ganglion cell population. Overexpression of ngn3 leads to ectopic induction of ngn1, yet, no induction of ngn3 was observed with ngn1 overexpression. These findings suggest ngn1 as a downstream genetic target of ngn3 and a linear inductive relationship of ngn3→ngn1. 

How and why ngn1 suppressed the expression of ash1, ath5, and ngn2 are unclear. One simple speculation is rivalry. It is plausible that ngn1 is expressed during the phase of photoreceptor genesis not only to promote photoreceptor production but also to suppress the expression of ash1, ath5, and ngn2 and thus attenuate the production of other cell types. Previous studies with similar experimental approaches showed that in the chick retina, overexpression of ath5 promotes ganglion cell production, ⁴⁶ overexpression of ash1 increases the amacrine cell population, ²⁴ and overexpression of ngn2 has no effects on retinal cell populations. ²⁴ Thus, ngn1 differed from these bHLH genes not only in its expression pattern but also in its effect on retinal neurogenesis from overexpression. 

The chick ngn1 displayed a distinctive pattern of expression coinciding with photoreceptor genesis, exhibited a photoreceptor-promoting activity, and repressed other regulatory genes whose expression persisted through late phases of retinal neurogenesis. These properties support ngn1 to play a role in guiding a progenitor cell to the path of developing into a photoreceptor. 

Footnotes

 Supported by National Institutes of Health/National Eye Institute Grant EY11640 and by an unrestricted grant to the Department of Ophthalmology at the University of Alabama at Birmingham from Research to Prevent Blindness.

Footnotes

 Disclosure: R.T. Yan, None; L. He, None; S.-Z. Wang, None

Footnotes

 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.

The authors thank Stephen Hughes for retroviral vector RCAS (B/P) and shuttle vector Cla12Nco.